Back to funds

GSK plc

institutionalUpdated 17 days ago

Managed by Gsk Plc • Latest filing Q3 2026

Portfolio value
$497M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-46.9%
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$799M
Q1 2026$599.2M
Q2 2026$602.2M
Q3 2026$497M

Top holdings

13 positions as of Q3 2026

View filing
C

CRISPR THERAPEUTICS AG

-19.0%
Value
$144.3M
Shares
2.61M
% Port
29.03%
V

VIR BIOTECHNOLOGY INC

Unchanged
Value
$95.6M
Shares
8.55M
% Port
19.23%
W

WAVE LIFE SCIENCES INC

Value
$67.5M
Shares
18.25M
% Port
13.58%
B

BIONTECH SE

-24.9%
Value
$65.7M
Shares
668.5K
% Port
13.22%
I

IDEAYA BIOSCIENCES INC

Unchanged
Value
$51.2M
Shares
1.33M
% Port
10.31%
C

CYTOKINETICS INC

Unchanged
Value
$22.4M
Shares
340.4K
% Port
4.51%
L

LYELL IMMUNOPHARMA INC

Unchanged
Value
$14.8M
Shares
1.51M
% Port
2.98%
?
8.N/A

SPERO THERAPEUTICS INC

Unchanged
Value
$11.1M
Shares
9.19M
% Port
2.24%
N

NKARTA INC

Unchanged
Value
$8.3M
Shares
3.15M
% Port
1.66%
?
10.N/A

FULCRUM THERAPEUTICS INC

Unchanged
Value
$6.6M
Shares
1.79M
% Port
1.33%
B

BICYCLE THERAPEUTICS PLC

Unchanged
Value
$5.6M
Shares
1.53M
% Port
1.13%
R

REGENXBIO INC

Unchanged
Value
$2M
Shares
271.5K
% Port
0.41%
C

CVRX INC

Unchanged
Value
$1.8M
Shares
1.01M
% Port
0.35%

Explore